Filing Details
- Accession Number:
- 0001209191-15-051961
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-10 17:56:33
- Reporting Period:
- 2015-06-10
- Filing Date:
- 2015-06-10
- Accepted Time:
- 2015-06-10 17:56:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516479 | Insys Therapeutics Inc. | INSY | Pharmaceutical Preparations (2834) | 510327886 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1617058 | Franc Fosse Del | C/O Insys Therapeutics, Inc. 1333 South Spectrum Blvd, # 100 Chandler AZ 85286 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-10 | 10,000 | $13.27 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-10 | 10,000 | $34.48 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-06-10 | 10,000 | $0.00 | 10,000 | $13.27 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,000 | 2024-05-18 | No | 4 | M | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.36 to $34.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This option was previously reported as an option for 30,000 shares at an exercise price of $26.55 per share, but was adjusted to reflect the 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
- The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 19, 2018.
- On June 5, 2015, the Issuer effected a 2-for-1 forward stock split, resulting in the reporting person's ownership of 30,000 additional options.
Billionaire Hedge Funds
